Detection of Toxoplasma gondii infection among diabetic patients in Turkey

Basit Öğe Kaydı
dc.authoridAlim, Mehtap/0000-0003-0818-7714
dc.contributor.authorOzcelik, Semra
dc.contributor.authorAlim, Mehtap
dc.contributor.authorOzpinar, Necati
dc.date.accessioned2024-10-26T18:07:52Z
dc.date.available2024-10-26T18:07:52Z
dc.date.issued2020
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractBackgound: In some recent studies, it has been suggested that there may be a relationship between Toxoplasma gondii (T. gondii) and type 2 diabetes mellitus (T2DM). T. gondii is of greater significance in these patients. Objectives: In the present study, it was aimed to investigate the seroprevalence of T. gondii in T2DM patients. Methods: To define Toxoplasma IgG and IgM seropositivity and determine the seroprevalence of toxoplasmosis in patients presenting at the Internal Diseases outpatient clinic of the Healthcare Application and Research Hospital, where the ELISA method was used. 200 T2DM patients and 100 healthy individuals with no complaints took part in the study. Results: Toxoplasma IgG positivity was determined in 53% of the 200 T2DM patients and Toxoplasma IgM positivity in 13%. While in the control group, Toxoplasma IgG positivity was determined in 27% and Toxoplasma IgM positivity in 1%. The risk of toxoplasmosis infection in T2DM patients was two folds higher than healthy controls according to the IgG results. IgM results were further differentiated. Conclusions: We believe that the seroprevalence of T. gondii is high in the T2DM patient group and that the causes should be investigated in more detail.
dc.description.sponsorshipCumhuriyet University Scientific Research Projects Unit [T-635]
dc.description.sponsorshipThis study was funded by the Cumhuriyet University Scientific Research Projects Unit (T-635).
dc.identifier.doi10.1016/j.cegh.2020.02.020
dc.identifier.endpage902
dc.identifier.issn2452-0918
dc.identifier.issn2213-3984
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85080076040
dc.identifier.scopusqualityQ2
dc.identifier.startpage899
dc.identifier.urihttps://doi.org/10.1016/j.cegh.2020.02.020
dc.identifier.urihttps://hdl.handle.net/20.500.12418/29713
dc.identifier.volume8
dc.identifier.wosWOS:000536855000045
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier - Division Reed Elsevier India Pvt Ltd
dc.relation.ispartofClinical Epidemiology and Global Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectToxoplasma gondii
dc.subjectDiabetic patients
dc.subjectSeroprevalence
dc.subjectELISA
dc.titleDetection of Toxoplasma gondii infection among diabetic patients in Turkey
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu